Search results for "Highlights"

Results 11 - 20 of about 418 for "Highlights".
Sort by: Relevance | Newest | Oldest

ADA updates Standards of Care in Diabetes

The updates, which were released by the American Diabetes Association (ADA) in June, cover therapy to delay onset of type 1 diabetes and screening for nonalcoholic fatty liver disease.
14 Jul 2023

Afternoon physical activity linked to greater HbA1c reduction than other times of day

A secondary analysis of the Look AHEAD (Action for Health in Diabetes) study found that participants who performed more moderate to vigorous physical activity in the afternoon versus other times of day had the greatest reduction in HbA1c compared to those who were inactive.
9 Jun 2023

EHR-based tool may help predict life expectancy in older patients with diabetes

The tool uses sex, body mass index, serum creatinine level, dementia, metastatic cancer, peripheral vascular disease, albuminuria, home oxygen use, wheelchair use, current smoking, and the interaction between age and heart failure to generate a risk score.
9 Jun 2023

HbA1c levels above 9% may be associated with higher dementia risk

A cohort study found higher dementia risk among type 2 diabetes patients ages 50 years and older whose HbA1c levels were usually in the 9% to 10% or 10% and above range compared to those with tighter glycemic control.
12 May 2023

Update in Endocrinology highlights top diabetes research of 2013

Ten studies from 2013 with potential to change endocrinology practice were summarized in Annals of Internal Medicine's annual Update in Endocrinology, published in the June 3 issue.
13 Jun 2014

GLP-1 receptor agonists associated with better primary CV prevention vs. DPP-4 inhibitors

A retrospective study compared cardiovascular (CV) outcomes among patients adding glucagon-like peptide-1 (GLP-1) receptor agonists, sodium-glucose cotransporter-2 inhibitors, or dipeptidyl peptidase-4 (DPP-4) inhibitors to metformin, sulfonylurea, or insulin treatment alone or in combination.
12 May 2023

No differences found in effects of secondary diabetes drugs on kidney outcomes

A trial found similar rates of progression to kidney disease among patients with type 2 diabetes who were randomized to add a sulfonylurea, a dipeptidyl peptidase-4 inhibitor, a glucagon-like peptide-1 receptor agonist, or basal insulin to metformin treatment.
9 Jun 2023

NSAID use linked to risk of heart failure hospitalization in type 2 diabetes

Danish patients with type 2 diabetes who took prescription NSAIDs had increased risk of first-time heart failure hospitalization, particularly if they were new users of the drugs or age 65 years or older, a recent study found.
14 Apr 2023

Younger patients often ration insulin due to cost, study finds

Data from the 2021 National Health Interview Survey indicate that one in five patients younger than age 65 years, who would not be eligible for the $35 monthly Medicare price cap, have skipped or reduced insulin doses or put off buying the drug to save money.
14 Apr 2023

Guaranteeing adequate carbs before postpartum oral glucose tolerance testing may not be necessary

An analysis of data from two prospective studies found no relationship between carbohydrate intake in the day or days before testing and glucose level 120 minutes after oral glucose tolerance testing.
12 May 2023

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next